Ji P - Search Results

1

Singh R, Ivaturi VD, Penzenstadler J, Liu T, Chen J, Marathe A, Ji P, Glaser R, Nikolov N, Sahajwalla C. Singh R, et al. Among authors: ji p. Clin Pharmacol Ther. 2021 Jul;110(1):98-107. doi: 10.1002/cpt.2218. Epub 2021 Mar 25. Clin Pharmacol Ther. 2021. PMID: 33626206

2

Dosing regimen determination for juvenile idiopathic arthritis: a review of studies during drug development.

Ji P, Chowdhury BA, Yim S, Sahajwalla CG. Ji P, et al. J Pharm Sci. 2012 Aug;101(8):2621-34. doi: 10.1002/jps.23184. Epub 2012 May 31. J Pharm Sci. 2012. PMID: 22653876 Review.

3

Regulatory review of acetaminophen clinical pharmacology in young pediatric patients.

Ji P, Wang Y, Li Z, Doddapaneni S, Hertz S, Furness S, Sahajwalla CG. Ji P, et al. J Pharm Sci. 2012 Dec;101(12):4383-9. doi: 10.1002/jps.23331. Epub 2012 Oct 16. J Pharm Sci. 2012. PMID: 23073837 Review.

4

The antibody drug absorption following subcutaneous or intramuscular administration and its mathematical description by coupling physiologically based absorption process with the conventional compartment pharmacokinetic model.

Zhao L, Ji P, Li Z, Roy P, Sahajwalla CG. Zhao L, et al. Among authors: ji p. J Clin Pharmacol. 2013 Mar;53(3):314-25. doi: 10.1002/jcph.4. Epub 2013 Feb 20. J Clin Pharmacol. 2013. PMID: 23426855

5

An overview of the pediatric medications for the symptomatic treatment of allergic rhinitis, cough, and cold.

Fan Y, Ji P, Leonard-Segal A, Sahajwalla CG. Fan Y, et al. Among authors: ji p. J Pharm Sci. 2013 Dec;102(12):4213-29. doi: 10.1002/jps.23720. Epub 2013 Nov 1. J Pharm Sci. 2013. PMID: 24185951 Review.

6

Clinical endpoint sensitivity in rheumatoid arthritis: modeling and simulation.

Ma L, Zhao L, Xu Y, Yim S, Doddapaneni S, Sahajwalla CG, Wang Y, Ji P. Ma L, et al. Among authors: ji p. J Pharmacokinet Pharmacodyn. 2014 Oct;41(5):537-43. doi: 10.1007/s10928-014-9385-x. Epub 2014 Oct 5. J Pharmacokinet Pharmacodyn. 2014. PMID: 25283268

7

Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 1: Binary Model).

Li L, Zhang Y, Ma L, Ji P, Yim S, Chowdhury B, Doddapaneni S, Liu J, Wang Y, Sahajwalla C. Li L, et al. Among authors: ji p. J Clin Pharmacol. 2017 Sep;57(9):1097-1106. doi: 10.1002/jcph.891. J Clin Pharmacol. 2017. PMID: 28817199 Clinical Trial.

8

Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 2: Continuous Model).

Li L, Zhang Y, Ma L, Ji P, Yim S, Chowdhury BA, Doddapaneni S, Liu J, Wang Y, Sahajwalla C. Li L, et al. Among authors: ji p. J Clin Pharmacol. 2017 Sep;57(9):1107-1125. doi: 10.1002/jcph.967. J Clin Pharmacol. 2017. PMID: 28817201 Clinical Trial.

9

A Model-Based Approach to Quantify the Time-Course of Anti-Drug Antibodies for Therapeutic Proteins.

Ren Y, Li L, Kirshner S, Wang Y, Sahajwalla C, Ji P. Ren Y, et al. Among authors: ji p. Clin Pharmacol Ther. 2019 Apr;105(4):970-978. doi: 10.1002/cpt.1267. Epub 2018 Dec 9. Clin Pharmacol Ther. 2019. PMID: 30372517

10

A Novel Pharmacokinetic Bridging Strategy to Support a Change in the Route of Administration for Biologics.

Ji P, Nikolov N, Seymour S, Glaser R, Ren Y, Li L, Marathe A, Ren Y, Chen J, He L, Pisal D, Yapa SWS, Wang Y, Sahajwalla C. Ji P, et al. J Pharm Sci. 2019 Jul;108(7):2490-2499. doi: 10.1016/j.xphs.2019.02.027. Epub 2019 Mar 12. J Pharm Sci. 2019. PMID: 30871994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,783 results

Search Page

Filters